Home › Laryngeal Cancer
Laryngeal Cancer clinical trials recruiting in the U.S.
28 studies for Laryngeal Cancer are recruiting participants at sites across the United States.
Cities with the most studies
- Atlanta, GA8 studies
- Chicago, IL7 studies
- Milwaukee, WI7 studies
- Portland, OR7 studies
- Baltimore, MD6 studies
- Kansas City, MO6 studies
- Richmond, VA6 studies
- Edison, NJ6 studies
- Irvine, CA6 studies
- Durham, NC6 studies
- Pittsburgh, PA6 studies
- St. Louis, MO6 studies
- Cincinnati, OH5 studies
- Houston, TX5 studies
- Aurora, IL5 studies
- Oklahoma City, OK5 studies
- Champaign, IL5 studies
- Charleston, IL5 studies
- Naperville, IL5 studies
- Cicero, IL5 studies
- Orange, CA5 studies
- Joliet, IL5 studies
- Danville, IL5 studies
- Ann Arbor, MI5 studies
- Omaha, NE5 studies
- Queens, NY5 studies
- Lansing, MI5 studies
- Fargo, ND5 studies
- Duluth, MN5 studies
- New York City, NY5 studies
- Tampa, FL4 studies
- Kansas City, KS4 studies
- Overland Park, KS4 studies
- Boston, MA4 studies
- Erie, PA4 studies
- Waukegan, IL4 studies
- O'Fallon, MO4 studies
- Des Moines, IA4 studies
- Evanston, IL4 studies
- Little Rock, AR4 studies
By state
- Arizona5 studies
- Arkansas5 studies
- California8 studies
- Colorado7 studies
- Connecticut3 studies
- Florida7 studies
- Georgia8 studies
- Idaho4 studies
- Illinois8 studies
- Indiana4 studies
- Iowa7 studies
- Kansas6 studies
- Kentucky3 studies
- Louisiana4 studies
- Maryland8 studies
- Massachusetts7 studies
- Michigan6 studies
- Minnesota7 studies
- Mississippi3 studies
- Missouri8 studies
- Montana5 studies
- Nebraska5 studies
- New Hampshire4 studies
- New Jersey7 studies
- New Mexico3 studies
- New York9 studies
- North Carolina8 studies
- North Dakota5 studies
- Ohio10 studies
- Oklahoma6 studies
- Oregon7 studies
- Pennsylvania7 studies
- South Carolina5 studies
- South Dakota3 studies
- Tennessee3 studies
- Texas6 studies
- Vermont3 studies
- Virginia7 studies
- Washington3 studies
- Wisconsin8 studies
Recently updated studies
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
RecruitingPhase 1/2
Ages 18 to 120 · All sexes · Updated Nov 13, 2026 · NCT07667400Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT05172245BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT05136196Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06589804PET/CT Assessment of Radiation-Induced Vascular Complications in Head and Neck Cancer
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06914999Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
RecruitingObservational study
Ages 21 to 90 · All sexes · Updated Nov 3, 2026 · NCT00900419Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07156227TMV Vaccine Alone or With Toripalimab-tpzi for Recurrent Head and Neck Squamous Cell Carcinoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT07898124Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT07195734Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT06980038Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 6, 2026 · NCT03010150Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers
RecruitingPhase 4
Ages 18 to 89 · All sexes · Updated Oct 5, 2026 · NCT07857655Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06997068Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT02734537Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06532279Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Recruiting
Ages 18 and older · All sexes · Updated Jul 16, 2026 · NCT06662058Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
Recruiting
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT01365169Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT07209189TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Mar 4, 2026 · NCT06868433A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 19, 2026 · NCT07063212Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 11, 2026 · NCT06636734Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Recruiting
Ages 18 and older · All sexes · Updated Feb 10, 2026 · NCT01473784CONFIRM: Magnetic Resonance Guided Radiation Therapy
Recruiting
Ages 18 and older · All sexes · Updated Feb 9, 2026 · NCT04368702Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
Recruiting
Ages 18 and older · All sexes · Updated Dec 11, 2025 · NCT05793151From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.